# Cass Information Systems Inc: financial statements, quarterly

CASS · Nasdaq · CIK 708781 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cass.md) · [Financials](/companies/cass/financials.md) · [Filings](/companies/cass/filings.md) · [Insiders](/companies/cass/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cass/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [31.8](/filings/0000708781-24-000091.md) | [12.0 d](/filings/0000708781-26-000010.md) | [27.7](/filings/0000708781-25-000063.md) | [27.6](/filings/0000708781-25-000087.md) | [28.1](/filings/0000708781-25-000105.md) | [26.5 d](/filings/0000708781-26-000010.md) | [26.8](/filings/0000708781-26-000022.md) | [27.2](/filings/0000708781-26-000031.md) | [27.4](/filings/0000708781-25-000105.md) | [26.2 d](/filings/0000708781-26-000010.md) | [26.5](/filings/0000708781-26-000022.md) | [27.4](/filings/0000708781-26-000031.md) |
| Interest expense | $m | [4.6](/filings/0000708781-24-000091.md) | [4.7 d](/filings/0000708781-25-000018.md) | [5.2](/filings/0000708781-24-000058.md) | [5.3](/filings/0000708781-24-000074.md) | [5.2](/filings/0000708781-24-000091.md) | [4.6 d](/filings/0000708781-25-000018.md) | [4.1](/filings/0000708781-26-000022.md) | [4.2 d](/filings/0000708781-26-000031.md) | [4.2 d](/filings/0000708781-25-000105.md) | not reported | [3.9](/filings/0000708781-26-000022.md) | [4.1 d](/filings/0000708781-26-000031.md) |
| Income tax | $m | [1.8](/filings/0000708781-24-000091.md) | [1.2 d](/filings/0000708781-26-000010.md) | [1.8](/filings/0000708781-25-000063.md) | [1.3](/filings/0000708781-25-000087.md) | [0.7](/filings/0000708781-25-000105.md) | [1.1 d](/filings/0000708781-26-000010.md) | [2.3](/filings/0000708781-26-000022.md) | [1.1](/filings/0000708781-26-000031.md) | [2.4](/filings/0000708781-25-000105.md) | [1.8 d](/filings/0000708781-26-000010.md) | [2.1](/filings/0000708781-26-000022.md) | [2.6](/filings/0000708781-26-000031.md) |
| Net income | $m | [7.4](/filings/0000708781-24-000091.md) | [8.4 d](/filings/0000708781-26-000010.md) | [7.2](/filings/0000708781-25-000063.md) | [4.5](/filings/0000708781-25-000087.md) | [2.9](/filings/0000708781-25-000105.md) | [4.6 d](/filings/0000708781-26-000010.md) | [9.0](/filings/0000708781-26-000022.md) | [8.9](/filings/0000708781-26-000031.md) | [9.1](/filings/0000708781-25-000105.md) | [8.2 d](/filings/0000708781-26-000010.md) | [8.8](/filings/0000708781-26-000022.md) | [10.6](/filings/0000708781-26-000031.md) |
| Diluted EPS | $ per share | [0.54](/filings/0000708781-24-000091.md) | not reported | [0.52](/filings/0000708781-25-000063.md) | [0.32](/filings/0000708781-25-000087.md) | [0.21](/filings/0000708781-25-000105.md) | not reported | [0.66](/filings/0000708781-26-000022.md) | [0.66](/filings/0000708781-26-000031.md) | [0.68](/filings/0000708781-25-000105.md) | not reported | [0.67](/filings/0000708781-26-000022.md) | [0.81](/filings/0000708781-26-000031.md) |
| Basic EPS | $ per share | [0.55](/filings/0000708781-24-000091.md) | not reported | [0.53](/filings/0000708781-25-000063.md) | [0.33](/filings/0000708781-25-000087.md) | [0.22](/filings/0000708781-25-000105.md) | not reported | [0.67](/filings/0000708781-26-000022.md) | [0.67](/filings/0000708781-26-000031.md) | [0.69](/filings/0000708781-25-000105.md) | not reported | [0.69](/filings/0000708781-26-000022.md) | [0.83](/filings/0000708781-26-000031.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,505](/filings/0000708781-24-000091.md) | [2,479](/filings/0000708781-26-000010.md) | [2,294](/filings/0000708781-25-000063.md) | [2,283](/filings/0000708781-25-000087.md) | [2,261](/filings/0000708781-25-000105.md) | [2,395](/filings/0000708781-26-000010.md) | [2,318](/filings/0000708781-26-000022.md) | [2,316](/filings/0000708781-26-000031.md) | [2,454](/filings/0000708781-25-000105.md) | [2,606](/filings/0000708781-26-000031.md) | [2,534](/filings/0000708781-26-000022.md) | [2,516](/filings/0000708781-26-000031.md) |
| Total liabilities | $m | [2,299](/filings/0000708781-23-000042.md) | [2,249](/filings/0000708781-25-000018.md) | [2,064](/filings/0000708781-24-000058.md) | [2,053](/filings/0000708781-24-000074.md) | [2,023](/filings/0000708781-24-000091.md) | [2,166](/filings/0000708781-26-000010.md) | [2,084](/filings/0000708781-25-000063.md) | [2,075](/filings/0000708781-25-000087.md) | [2,210](/filings/0000708781-25-000105.md) | [2,363](/filings/0000708781-26-000031.md) | [2,292](/filings/0000708781-26-000022.md) | [2,272](/filings/0000708781-26-000031.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [206](/filings/0000708781-24-000091.md) | [230](/filings/0000708781-26-000010.md) | [229](/filings/0000708781-25-000087.md) | [230](/filings/0000708781-25-000105.md) | [238](/filings/0000708781-25-000105.md) | [229](/filings/0000708781-26-000031.md) | [234](/filings/0000708781-26-000031.md) | [241](/filings/0000708781-26-000031.md) | [243](/filings/0000708781-25-000105.md) | [243](/filings/0000708781-26-000031.md) | [242](/filings/0000708781-26-000031.md) | [245](/filings/0000708781-26-000031.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.4 d](/filings/0000708781-24-000091.md) | [7.6 d](/filings/0000708781-26-000010.md) | [9.8](/filings/0000708781-25-000063.md) | [10.7 d](/filings/0000708781-25-000087.md) | [(0.2) d](/filings/0000708781-25-000105.md) | [18.6 d](/filings/0000708781-26-000010.md) | [21.6](/filings/0000708781-26-000022.md) | [(1.3) d](/filings/0000708781-26-000031.md) | [12.3 d](/filings/0000708781-25-000105.md) | [4.8 d](/filings/0000708781-26-000010.md) | [14.5](/filings/0000708781-26-000022.md) | [16.9 d](/filings/0000708781-26-000031.md) |
| Capital expenditure | $m | [3.0 d](/filings/0000708781-24-000091.md) | [2.6 d](/filings/0000708781-26-000010.md) | [3.5](/filings/0000708781-25-000063.md) | [2.8 d](/filings/0000708781-25-000087.md) | [2.0 d](/filings/0000708781-25-000105.md) | [0.2 d](/filings/0000708781-26-000010.md) | [2.6](/filings/0000708781-26-000022.md) | [1.3 d](/filings/0000708781-26-000031.md) | [1.0 d](/filings/0000708781-25-000105.md) | [0.7 d](/filings/0000708781-26-000010.md) | [1.9](/filings/0000708781-26-000022.md) | [3.1 d](/filings/0000708781-26-000031.md) |
| Dividends paid | $m | [3.9 d](/filings/0000708781-24-000091.md) | [4.1 d](/filings/0000708781-26-000010.md) | [4.1](/filings/0000708781-25-000063.md) | [4.1 d](/filings/0000708781-25-000087.md) | [4.1 d](/filings/0000708781-25-000105.md) | [4.2 d](/filings/0000708781-26-000010.md) | [4.2](/filings/0000708781-26-000022.md) | [4.1 d](/filings/0000708781-26-000031.md) | [4.1 d](/filings/0000708781-25-000105.md) | [4.1 d](/filings/0000708781-26-000010.md) | [4.1](/filings/0000708781-26-000022.md) | [4.1 d](/filings/0000708781-26-000031.md) |
| Share repurchases | $m | [2.8 d](/filings/0000708781-24-000091.md) | [0.6 d](/filings/0000708781-26-000010.md) | [1.1](/filings/0000708781-25-000063.md) | [0.0 d](/filings/0000708781-25-000087.md) | [2.7 d](/filings/0000708781-25-000105.md) | [3.5 d](/filings/0000708781-26-000010.md) | [5.1](/filings/0000708781-26-000022.md) | [5.9 d](/filings/0000708781-26-000031.md) | [6.7 d](/filings/0000708781-25-000105.md) | [8.3 d](/filings/0000708781-26-000010.md) | [2.9](/filings/0000708781-26-000022.md) | [3.1 d](/filings/0000708781-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.8](/filings/0000708781-23-000042.md) | [13.9](/filings/0000708781-24-000058.md) | [13.9](/filings/0000708781-24-000074.md) | [13.8](/filings/0000708781-24-000091.md) | [13.8](/filings/0000708781-25-000063.md) | [13.8](/filings/0000708781-25-000087.md) | [13.8](/filings/0000708781-25-000105.md) | [13.6](/filings/0000708781-26-000022.md) | [13.6](/filings/0000708781-26-000031.md) | [13.4](/filings/0000708781-25-000105.md) | [13.2](/filings/0000708781-26-000022.md) | [13.1](/filings/0000708781-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,806,149 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000708781-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.